Fundz

Tempest Therapeutics, Inc. to Explore Strategic Alternatives to Advance Clinical Oncology Assets

Apr 09, 2025

Contract Type

partnership

San FranciscoBiotechnologyHealthcareHealth CareTherapeuticsBiopharma

Description

Tempest Therapeutics, Inc. has announced plans to explore a full range of strategic alternatives to advance its promising clinical stage programs and maximize stockholder value. The company is considering mergers, acquisition, partnerships, joint ventures, licensing arrangements, or other strategic transactions, and has obtained the support of MTS Health Partners, L.P. for the strategic evaluation process.

Company Information

Company

Tempest Therapeutics

Location

ONE SANSOME STREET

San Francisco, California, United States

About

Tempest Therapeutics is a development-stage biotechnology company.

Related People

Stephen
Senior decision-maker at this company
••••••••@••••••••

See Stephen's verified email →

Justin
Likely contact at this company
••••••••@••••••••

See Justin's verified email →

Matt
Senior decision-maker at this company
••••••••@••••••••

See Matt's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tempest Therapeutics's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Tempest Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.